CVD Risk in RA Differs from CVD Risk in General Population
EULAR 2016: Cardiovascular disease risk in rheumatoid arthritis is quite different from risk factors in the general population. Risk calculators should be different too, experts say.
Communication and Compliance Go Hand in Hand
EULAR 2016: Patient education and compliance often take a back seat to disease management, but they need to be at the forefront of care.
Secukinumab Provides Sustained Improvements in AS
EULAR 2016: Secukinumab prevents radiographic progression in 80 percent of ankylosing spondylitis patients and provides sustained improvements.
Secukinumab Study Focuses on Inflammatory Bowel Disease
EULAR 2016: Inflammatory bowel disease is commonly associated with psoriasis, psoriatic arthritis and ankylosing spondylitis.
The Severity of Osteoarthritis Symptoms Often Overlooked
EULAR 2016: A new study shows that patients with osteoarthritis may carry a greater burden of disease than patients with rheumatoid arthritis.
Air Pollution Linked to Pediatric Lupus
EULAR 2016: A new study shows an association between daily exposure to air pollutants and childhood-onset systemic lupus erythematous.
Ixekizumab Associated with Significant Improvements in PsA
EULAR 2016: Ixekizumab significantly helped signs and symptoms of psoriatic arthritis in a phase 3 study reported this week.
By clicking Accept, you agree to become a member of the UBM Medica Community.